KR860001789A - 디히드로피리딘 유도체의 제조방법 - Google Patents

디히드로피리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR860001789A
KR860001789A KR1019850005705A KR850005705A KR860001789A KR 860001789 A KR860001789 A KR 860001789A KR 1019850005705 A KR1019850005705 A KR 1019850005705A KR 850005705 A KR850005705 A KR 850005705A KR 860001789 A KR860001789 A KR 860001789A
Authority
KR
South Korea
Prior art keywords
group
general formula
following general
derivative represented
lower alkoxy
Prior art date
Application number
KR1019850005705A
Other languages
English (en)
Other versions
KR930009452B1 (ko
Inventor
신지 니시따니 (외 4)
Original Assignee
오오쓰까 아끼히꼬
오오쓰까 세이야꾸 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오오쓰까 아끼히꼬, 오오쓰까 세이야꾸 가부시기가이샤 filed Critical 오오쓰까 아끼히꼬
Publication of KR860001789A publication Critical patent/KR860001789A/ko
Application granted granted Critical
Publication of KR930009452B1 publication Critical patent/KR930009452B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

디히드로피리딘 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 다음 일반식(2)로 표시되는 페닐 유도체와 다음 일반식(3)으로 표시되는 엔아민 유도체를 반응시킴을 특징으로 하는 다음 일반식(1)로 표시하는 디히드로피리딘 유도체 및 그의 염 및 에스테르의 제조방법.
  3. 〔상기식에서, R1,R2및 R4는 각각 저급알킬기이고; R3는 니트로기 또는 치환체로서 1 내지 3개의 할로겐원자를 갖을 수 있는 저급알킬기이고; R5는 저급알콕시기, 할로겐원자, 저급알킬티오기, 히드록실기, 저급알카노일옥시기, 테트라히드로피라닐옥시기 및 저급 알콕시-저급알콕시기로 구성되는 기로부터 선택된 1 내지 3개의 치환체를 갖을 수 있는 페닐기이고; 및는 불포화된 직쇄 또는 측쇄탄화수소 잔기이다.〕
  5. 〔상기식에서, R1,R3및 R4는 상기에 정의한 바와 같다.〕
  7. 〔상기식에서, R2,R5및는 상기에 정의한 바와 같다.〕
KR1019850005705A 1984-08-07 1985-08-07 디히드로피리딘 유도체, 그의 염 및 그의 에스테르의 제조방법 KR930009452B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59165797A JPS6143165A (ja) 1984-08-07 1984-08-07 ジヒドロピリジン誘導体の製造法
JP165797/84 1984-08-07

Publications (2)

Publication Number Publication Date
KR860001789A true KR860001789A (ko) 1986-03-22
KR930009452B1 KR930009452B1 (ko) 1993-10-04

Family

ID=15819171

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850005705A KR930009452B1 (ko) 1984-08-07 1985-08-07 디히드로피리딘 유도체, 그의 염 및 그의 에스테르의 제조방법

Country Status (7)

Country Link
US (1) US4795814A (ko)
EP (1) EP0173126B1 (ko)
JP (1) JPS6143165A (ko)
KR (1) KR930009452B1 (ko)
DE (1) DE3575295D1 (ko)
DK (1) DK173807B1 (ko)
ES (1) ES8607932A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
US4761420A (en) * 1986-06-13 1988-08-02 Laboratoires Syntex S.A. Antihypertensive dihydropyridine derivatives
IT1275939B1 (it) 1995-03-20 1997-10-24 Lusochimica Spa Procedimento per la preparazione di 4 (nitrofenil) diidropiridine
CA2425561C (en) * 2003-04-14 2007-09-18 Brantford Chemicals Inc. Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof
CN105384682B (zh) * 2015-12-21 2018-04-20 芮城县虹桥药用中间体有限公司 一种西尼地平的制备方法
CN111072552B (zh) * 2019-12-11 2021-06-04 湖南九典制药股份有限公司 西尼地平的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
EP0173126B1 (en) 1990-01-10
ES8607932A1 (es) 1986-06-01
DK357385D0 (da) 1985-08-06
DK173807B1 (da) 2001-11-12
EP0173126A1 (en) 1986-03-05
ES545935A0 (es) 1986-06-01
JPS6143165A (ja) 1986-03-01
KR930009452B1 (ko) 1993-10-04
JPH0153873B2 (ko) 1989-11-15
US4795814A (en) 1989-01-03
DK357385A (da) 1986-03-11
DE3575295D1 (en) 1990-02-15

Similar Documents

Publication Publication Date Title
KR870002125A (ko) 피리딘 유도체의 제조방법
KR880013888A (ko) 신규 디티오아세탈 화합물, 그의 제조방법 및 이 화합물로 되는 제약 조성물
KR880001651A (ko) 이미다조 [4,5-b] 피리딘 유도체, 그의 제조방법 및 그를 함유하는 항궤양제
KR830009054A (ko) 아미노피리미딘 유도체의 제조방법
KR840009092A (ko) 벤조푸란-또는 벤조피란-카르복사미드 유도체의 제조방법
KR860009023A (ko) 치환된 실릴기를 갖는 신규 에테르 화합물의 제조방법
EP0185324A3 (en) Novel organic trithio oxides and method for the preparation thereof
KR880002823A (ko) 약제학적 화합물
KR850005829A (ko) 2-시아노벤즈이미다졸 유도체의 제조방법
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
KR850001184A (ko) 1,5-벤조티아제핀 유도체의 제조방법
KR860001789A (ko) 디히드로피리딘 유도체의 제조방법
KR850005845A (ko) 7-아미노-3-치환된-메틸-3-세펨-4-카복실산 및 그의 저급 알킬실릴 유도체의 제조방법
KR840006482A (ko) 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법
KR860001065A (ko) 4-아세톡시-3-히드록시에틸아제티진-2-온유도체의 제조방법
KR870001214A (ko) 4,7-디히드로티에노[2,3-b]피리딘 유도체의 제조방법
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR870003092A (ko) 피리딘 유도체의 제조방법
KR840008342A (ko) 모르포린 유도체의 제조방법
KR840005723A (ko) 티아졸유도체의 제조방법
KR920700215A (ko) 비스(1,2-디아릴-1,2-에틸렌디티오레이토)니켈-기재 착물의 제조방법
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR860003212A (ko) 2-피리딘-티올 유도체 및 그의 산부가염의 제조 방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR830006285A (ko) 벤조퀴놀리진의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20041004

Year of fee payment: 12

EXPY Expiration of term